RYAH Medtech: Data Insights for the Global Medical Plant Industry

RYAH Medtech Inc. has launched its campaign on the Investing News Network’s technology channel.

RYAH Medtech has developed a digital ecosystem capable of leveraging the internet of things (IoT) and artificial intelligence (AI) to create data-driven services for the medical plant industry. The company’s dose-measuring vaporizer allows patients to carefully control their own dosing while also providing dispensaries and licensed producers with HIPPA-compliant data regarding strain consumption patterns. RYAH’s vaporizer base is a one-time purchase that uses specially-designed cartridges that can be purchased by dispensaries, licensed producers and pharmacies, ensuring a recurring revenue stream.

RYAH expects to be selling its vaporizer and cartridges across Canada and the United States in the coming year. The company has already produced over 100,000 cartridges in addition to 1,200 vaporizers. RYAH recently received its medical establishment license from Health Canada for its cartridges, which is expected to provide more credibility to RYAH as a leading plant-based delivery system and medical data provider.

RYAH Medtech’s company highlights include the following:

• RYAH utilizes a recurring, commercial-stage revenue model with a multi-prong strategy to generate revenue.
• First AI system to fingerprint cannabinoids and map for medical conditions
• Substantial IP portfolio with three global patents pending.
• Owns a highly-recognized brand that has drawn media attention and prestige in the medical CBD and plant-based market.
• RYAH’s database contains over 180,000 patients and participants.
• RYAH has produced 100,000 cartridges and 1,200 devices to date.
• Received Health Canada medical establishment license in June 2019.

Click here to connect with RYAH Medtech for an investor presentation.